Subscribe to our Newsletters !!
Although copying the blueprint is extremely comple
Eppendorf introduces a new addition to their Eppen
The recent rabies death of an 11 year old Canadian
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micro
China has affirmed beginning period human tests for two exploratory antibodies to battle the new coronavirus that killed more than 100,000 individuals around the world, state media Xinhua provided details regarding Tuesday.
The antibodies are being created by a Beijing-based unit of Nasdaq-recorded Sinovac Biotech, and by the Wuhan Institute of Biological Products, an offshoot of state-possessed China National Pharmaceutical Group.
In March, China gave the green-light for another clinical preliminary for a coronavirus immunization competitor created by military-upheld China’s Academy of Military Medical Sciences and HK-recorded biotech firm CanSino Bio, soon after U.S. tranquilize designer Moderna said it had started human tests for their immunization with the U.S. National Institutes of Health.
